| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 31 |
| 1 | AMLODIPINE | 21 |
| 2 | LANSOPRAZOLE | 19 |
| 3 | APIXABAN | 18 |
| 4 | ASPIRIN | 16 |
| 5 | ASPIRIN 325 MG | 16 |
| 6 | ASPIRIN 81 MG | 16 |
| 7 | FUROSEMIDE | 15 |
| 8 | PREDNISOLONE | 15 |
| 9 | PREDNISOLONE ORAL | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 1 | 0.0014 |
| 1 | ETELCALCETIDE | 4 | 0.0014 |
| 2 | HEPARIN SODIUM AND DEXTROSE | 1 | 0.0014 |
| 3 | TRABECTEDIN | 3 | 0.0013 |
| 4 | EDARAVONE | 2 | 0.0012 |
| 5 | EDOXABAN TOSYLATE | 8 | 0.0012 |
| 6 | NICARDIPINE | 5 | 0.0011 |
| 7 | MIGLITOL | 1 | 0.0010 |
| 8 | DAPRODUSTAT | 2 | 0.0010 |
| 9 | SUCROFERRIC OXYHYDROXIDE | 3 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Phosphate Binder [EPC] | 3 | 0.0010 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 6 | 0.0010 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 6 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 7 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 8 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |